Navigation Links
The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.
Date:8/5/2009

in the United States entirely devoted to clinical research, with more than 1,500 studies currently in progress, most of which are clinical trials. These clinical trials play a crucial role in evaluating potential therapeutic treatments for many critical health challenges facing the U.S. and the rest of the world. Since the Clinical Center's opening in 1953, more than 350,000 patients from all 50 states and around the world have participated in its clinical research.

About the Foundation for the National Institutes of Health

The Foundation for the National Institutes of Health was established by the United States Congress to support the mission of the National Institutes of Health - improving health through scientific discovery. The Foundation identifies and develops opportunities for innovative public-private partnerships and collaborations and brings together industry, academia, and the philanthropic community in support of the efforts of the NIH. As a non-profit, 501(c)(3) corporation, the Foundation raises private-sector funds for a broad portfolio of unique programs that complement and enhance NIH priorities and activities. The Foundation's Web site address is http://www.fnih.org.

The NIH - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

About sanofi-aventis

Sanofi-aventis is a leading global pharmaceutical company that discovers, dev
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
5. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
6. The Parkinsons Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinsons Disease
7. Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship
8. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
9. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
10. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
11. eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...eDesignC or p.(IDC)announcedtodaythatDr.BruceL.A.C...successfultrackrec or dinbiotechnologyexecutiveman...oGenetics,inSeattle,WAandChiefScientificOfficeratN...p://www.newscom.com/cgi-bin/prnh/20091123/SF15228 ...eOfficercommented,"IamdelightedtowelcomeDr.BruceCa...
(Date:11/20/2009)..., , , , , , , , ...of scientists from Washington University in St. Lo... Laboratory and Iowa State University has finished... Click here for more information. , , ... , , , , , , , , , ...
(Date:11/20/2009)... Karolinska Development AB today,a...as entered into a,co-investment agreement with the...y Karolinska Development and used to invest in the... and medical technology companies. EIF,has agreed ...The agreement,represents EIF,s largest single inve...
(Date:11/19/2009).../ -- Danish Prince Joachim inaugurated the DONG En...dborg, Denmark, on Wednesday, November 18. The fac...generation ethanol demonstration biorefineries. Ge...,s innovative process for converting straw to fuel...o market with commercial enzymes for converting ce...
Breaking Biology Technology:Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
..., Calif. - Lawrence Livermore National Laboratory ... a solid as it evolves on the ultra-fast timescale...FEL) pulses, the team, led by Anton Barty, is able... formation, phase separation, rapid fluctuations i...ironments. Other Livermore scientists include Mich...
...Colo., June 23 Replidyne, Inc.,(Nasdaq: RDYN ) t...s license,agreement with Asubio Pharma Co., Ltd. f... with this decision, the Company also announced th...bio Pharma Co., Ltd. and Nippon,Soda Co. Ltd. for ... as a,result of the Company being unable to secure...
....-based Biorepositories Event for the Pharmaceutic...s, INDIANAPOLIS, June 23 BioStorage Technologies...materials storage, sample,management and cold chai...hip of Institute for International Research,s (IIR...sed event for the pharmaceutical and,biotech indus...
Other Biology Technology:A look into the nanoscale 2Replidyne Terminates Faropenem Agreements 2Replidyne Terminates Faropenem Agreements 3BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008 2
(Date:11/23/2009)...e highest resolution images of peptides attaching ...rstanding how biomolecules manipulate the growth c... for kidney stones using biomolecules. , The res... of the journal Proceedings of the National Acade...th mineral surfaces by accelerating, switching and...
(Date:11/23/2009)...sity of Alabama at Birmingham (UAB) researchers sh...ical conditions (co-morbidity) do not explain the ...s compared to Caucasians who also have colon cance...r , a journal of the American Cancer Society. , ...bidity are independent predictors of poor survival...
(Date:11/23/2009)...unprecedented detail how the ribosome interacts wi...ide them toward their destination in biological ce...fitting (MDFF) to examine the interaction of the r... The first study, in Proceedings of the National...ling between the ribosome and an elongation factor...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit 13968 1China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit 13968 2China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit 13968 3Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 1Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 2Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 3Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 4Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 5Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 6NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 1NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 2NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 3NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 4
...our mate,s rendition of Marvin Gaye,s "Let,s Get i...ther times? A songbird study conducted by Emory Un... that a change in hormone levels may alter the way...rain nuclei, common to all vertebrates, called the...uch as courtship, parenting and aggression depend ...
...R, Mich.---Scientists and news organizations typic...uring epidemics, but research at the University of...ions lurking in large numbers of people are the ke...lly fatal infectious disease: cholera. , Using a ...researchers and their collaborators came up with r...
...has become one of the most widely used medications..., fevers, inflammation, and blood clotting. In ani...t atherosclerosis, though none of its known mechan...a new study, though, researchers have uncovered th...prevent arterial plaque buildup. , Using cell cu...
Other Biology News:Is that song sexy or just so-so? 2Hidden infections crucial to understanding, controlling disease outbreaks 2Hidden infections crucial to understanding, controlling disease outbreaks 3
Cryopreservation medium, preadipocytes from Zen-Bio, Inc.
5X MEGAscript® T7 Kit from Ambion
Mouse Anti-Rad 51C Monoclonal Antibody, Unconjugated, Clone 2H11/6 from ABR-Affinity BioReagents
Flexi Rabbit Reticulocyte Lysate System from Promega
Biology Products: